Healthcare provider profile · identity verified

Richa Sharma, M.D

Allopathic & Osteopathic Physicians|Internal Medicine · WICHITA, KS · NPI 1669408480

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Richa Sharma, M.D received $17.01 in general payments during 2025 across 1 reported records.

ABIOMED accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$17.01

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABIOMED	Unresolved — no canonical attribution shown	$17.01	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$17.01	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	814	146
Atorvastatin Calcium	Atorvastatin Calcium	598	176
Amlodipine Besylate	Amlodipine Besylate	517	144
Gabapentin	Gabapentin	410	86
Omeprazole	Omeprazole	384	104
Levothyroxine Sodium	Levothyroxine Sodium	380	103
Losartan Potassium	Losartan Potassium	345	90
Lisinopril	Lisinopril	313	81
Simvastatin	Simvastatin	302	68
Tizanidine Hcl	Tizanidine Hcl	294	71
Furosemide	Furosemide	258	80
Pantoprazole Sodium	Pantoprazole Sodium	230	61
Tramadol Hcl	Tramadol Hcl	230	70
Fluticasone Propionate	Fluticasone Propionate	203	96
Metoprolol Succinate	Metoprolol Succinate	191	52
Albuterol Sulfate Hfa	Albuterol Sulfate	189	71
Trazodone Hcl	Trazodone Hcl	173	33
Glipizide Er	Glipizide	170	40
Metformin Hcl	Metformin Hcl	161	40
Azithromycin	Azithromycin	154	111
Citalopram Hbr	Citalopram Hydrobromide	144	31
Allopurinol	Allopurinol	137	37
Metformin Hcl Er	Metformin Hcl	135	35
Hydrochlorothiazide	Hydrochlorothiazide	133	35
Sertraline Hcl	Sertraline Hcl	132	36
Meloxicam	Meloxicam	127	41
Prednisone	Prednisone	126	85
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	125	31
Potassium Chloride	Potassium Chloride	123	29
Tamsulosin Hcl	Tamsulosin Hcl	120	32
Alendronate Sodium	Alendronate Sodium	115	30
Ozempic	Semaglutide	106	19
Triamcinolone Acetonide	Triamcinolone Acetonide	103	45
Mirtazapine	Mirtazapine	97	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	32
Carvedilol	Carvedilol	95	25
Buspirone Hcl	Buspirone Hcl	92	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	22
Oxybutynin Chloride Er	Oxybutynin Chloride	89	21
Alprazolam	Alprazolam	87	25
Metoprolol Tartrate	Metoprolol Tartrate	82	23
Fluoxetine Hcl	Fluoxetine Hcl	78	16
Donepezil Hcl	Donepezil Hcl	76	22
Famotidine	Famotidine	73	22
Rosuvastatin Calcium	Rosuvastatin Calcium	69	23
Escitalopram Oxalate	Escitalopram Oxalate	67	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	suppressed
Eliquis	Apixaban	62	12
Bumetanide	Bumetanide	61	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	19
Zolpidem Tartrate	Zolpidem Tartrate	59	20
Cephalexin	Cephalexin	57	47
Ibuprofen	Ibuprofen	57	12
Warfarin Sodium	Warfarin Sodium	57	13
Pravastatin Sodium	Pravastatin Sodium	54	16
Atenolol	Atenolol	52	15
Duloxetine Hcl	Duloxetine Hcl	52	15
Benazepril Hcl	Benazepril Hcl	49	14
Propranolol Hcl	Propranolol Hcl	49	12
Hydralazine Hcl	Hydralazine Hcl	48	16
Bupropion Xl	Bupropion Hcl	47	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	39
Venlafaxine Hcl Er	Venlafaxine Hcl	44	17
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Synthroid	Levothyroxine Sodium	40	suppressed
Mounjaro	Tirzepatide	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Acyclovir	Acyclovir	37	18
Fluconazole	Fluconazole	37	21
Pregabalin	Pregabalin	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Celecoxib	Celecoxib	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	12
Acetaminophen-Codeine	Acetaminophen With Codeine	27	13
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	17
Glipizide	Glipizide	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Linzess	Linaclotide	22	suppressed
Metronidazole	Metronidazole	22	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Amoxicillin	Amoxicillin	19	19
Finasteride	Finasteride	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Hydrocortisone	Hydrocortisone	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Nystatin	Nystatin	16	12
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	13
Estradiol	Estradiol	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Diazepam	Diazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Methimazole	Methimazole	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$17.01 · 1 records	ABIOMED	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error